Morgan Stanley Lowers RXO (NYSE:RXO) Price Target to $25.00

RXO (NYSE:RXO) had its price objective reduced by Morgan Stanley from $27.00 to $25.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 22.10% from the company’s previous close.

A number of other analysts have also recently commented on RXO. Jefferies Financial Group lowered their target price on shares of RXO from $33.00 to $30.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Citigroup cut shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price for the company. in a research note on Tuesday, November 12th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $29.00 target price on shares of RXO in a research note on Monday, November 18th. Stifel Nicolaus lifted their target price on shares of RXO from $26.00 to $27.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Benchmark reiterated a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $26.14.

RXO Stock Down 4.6 %

Shares of RXO stock opened at $20.48 on Thursday. The firm’s 50 day moving average price is $25.59 and its 200-day moving average price is $27.44. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. RXO has a 52-week low of $18.75 and a 52-week high of $32.82. The company has a market cap of $3.29 billion, a P/E ratio of -10.34, a PEG ratio of 3.98 and a beta of 1.53.

RXO (NYSE:RXO) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. On average, sell-side analysts predict that RXO will post 0.12 EPS for the current fiscal year.

Institutional Trading of RXO

Hedge funds have recently added to or reduced their stakes in the company. FMR LLC boosted its holdings in RXO by 439.5% during the third quarter. FMR LLC now owns 47,837 shares of the company’s stock worth $1,339,000 after buying an additional 38,970 shares in the last quarter. Harbor Capital Advisors Inc. purchased a new stake in RXO during the fourth quarter worth $2,004,000. JPMorgan Chase & Co. boosted its holdings in RXO by 71.8% during the third quarter. JPMorgan Chase & Co. now owns 272,062 shares of the company’s stock worth $7,618,000 after buying an additional 113,685 shares in the last quarter. Citigroup Inc. boosted its holdings in RXO by 132.4% during the third quarter. Citigroup Inc. now owns 196,748 shares of the company’s stock worth $5,509,000 after buying an additional 112,073 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in RXO by 7.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,068,380 shares of the company’s stock worth $57,915,000 after buying an additional 136,886 shares in the last quarter. 92.73% of the stock is owned by hedge funds and other institutional investors.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.